Nasdaq: RARE
Ultragenyx Pharmaceutical insiders
The officers, directors and 10% owners of Ultragenyx Pharmaceutical Inc. who hold the most stock, valued at the live RARE price.
$17.22
RARE today −$510K (−2.88%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 3
- Their RARE stock
- $85.5M
- Market value
- $1.76B
- Held by ranked insiders
- 4.87%
Insiders by value of RARE holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Emil D. Kakkis | President & CEO | 4,853,709 | $83.6M | 4.76% | 1715th |
| 2 | Mardi Dier | CFO & Executive Vice President | 66,695 | $1.1M | <0.1% | 12612th |
| 3 | Camille L. Bedrosian | EVP and Chief Medical Officer | 46,720 | $805K | <0.1% | 9589th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Ultragenyx Pharmaceutical; see each profile for the filing.